Indonesia Tightens Regulations on Vape Liquids Containing Etomidate

New Classification Under Narcotics Law

The Indonesian government has taken a significant step in regulating vape products by classifying etomidate, a substance found in certain vape liquids, as a Narcotic Class II drug. This decision was formalized through the Minister of Health Regulation No. 15/2025, which was enacted in early December 2025. The new regulation effectively places vape products containing etomidate under the purview of the Narcotics Law, thereby imposing stricter controls on their sale and use.

Legal Implications for Users and Sellers

With etomidate now classified as a narcotic, both users and sellers of vape products containing this substance face potential legal consequences. Previously, violations related to such vape liquids were primarily subject to administrative health sanctions. However, under the new regulatory framework, offenders can be prosecuted under the Narcotics Law, which carries more severe penalties. The National Police's Narcotics Crime Directorate has emphasized that this change provides a new legal basis for law enforcement actions against those involved in the distribution and consumption of these vape products.

Enforcement and Rehabilitation

Brigadier General Eko Hadi Santoso, Director of Narcotics Crime at the National Police's Criminal Investigation Body (Bareskrim Polri), clarified that users of vape products containing etomidate may not only face legal prosecution but could also be recommended for rehabilitation under the Narcotics Law. This approach reflects a balanced strategy that combines punitive measures with health-focused interventions. The enforcement of this new regulation is expected to have a significant impact on both the vape industry and consumers, particularly those using vape products containing etomidate.

Market and Public Health Implications

The classification of etomidate as a narcotic is likely to have far-reaching implications for the vape industry in Indonesia. Manufacturers and retailers will need to ensure compliance with the new regulations, potentially reformulating products to exclude etomidate or halting the sale of affected products altogether. For consumers, the change means increased legal risks associated with the use of certain vape liquids, as well as potential access to rehabilitation programs for those affected by substance abuse.